Summer Infant (SUMR) 8-K KBL Healthcare Acquisition Corp. II

EXHIBIT 99.2

Summer Infant, Inc. and Affiliates

Consolidated Balance Sheets

(Unaudited)

(in thousands of US dollars)

	As of June 30, 2006		As of December 31, 2005
Cash and equivalents	$	90	$	1,115
Trade receivables		7,905		6,542
Inventory		9,711		7,860
Prepaid expenses		316		198
Total current assets		18,022		15,716
Property and equipment, net		3,013		2,342
Goodwill and intangibles		174		182
Total assets	$	21,210	$	18,240
Line of credit	$	8,991	$	7,087
Accounts payable		5,357		6,711
Accrued expenses		1,505		958
Notes payable – short term		280		280
Total current liabilities		16,134		15,027
Notes payable – long term		920		560
Total liabilities		17,054		15,587
Common stock & paid in capital		133		133
Retained earnings		2,103		1,306
Total stockholders equity		4,156		2,661
Total liabilities & stockholders equity	$	21,210	$	18,240

Consolidated balance sheets and statements of operations were prepared by Summer Infant as a private company, in accordance with U.S. generally accepted accounting principles and may not conform to SEC Regulation S-X. Accordingly, such historical information may be adjusted and presented differently in our proxy statement to solicit stockholder approval of the acquisition.

Summer Infant, Inc. and Affiliates

Consolidated Statements of Operations

(Unaudited)

(in thousands of US dollars)

	Six Months Ended June 30					Fiscal Year Ended December 31, 2005
	2006			2005
Net sales	$	26,133		$	16,651	$	35,426
Cost of goods sold		16,254			11,212		23,317
Gross profit		9,879			5,439		12,109
Selling, general & administrative expenses		7,433			4,449		10,058
Depreciation & amortization		288			156		380
Income from operations		2,158			834		1,671
Interest expense		402			117		448
Other expense/(income)		(2	)		0		1
Net income	$	1,758		$	717	$	1,223
EBITDA	$	2,448		$	990	$	2,051

Consolidated balance sheets and statements of operations were prepared by Summer Infant as a private company, in accordance with U.S. generally accepted accounting principles and may not conform to SEC Regulation S-X. Accordingly, such historical information may be adjusted and presented differently in our proxy statement to solicit stockholder approval of the acqusition.